Beckman Coulter Lipase recall
Beckman Coulter Lipase, REF OSR6130 and OSR6230.
Why was Beckman Coulter Lipase recalled?
NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots
- Product
- Beckman Coulter Lipase, REF OSR6130 and OSR6230.
- Recalling firm
- Beckman Coulter Inc.
- Quantity
- 20,926 units
- Distribution
- Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
- Recall date
- October 30, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (device)